Overview
AI target discovery, RNA sequence optimization, and small nucleic acid drug development
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records.
No chartable funding estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 22, 2026 | — · Equity | 光华梧桐, 晓池资本, 梧桐聚云企管, 瑞尚医药 | No source link |
Evidence Yunhe Pharma Secures Equity InvestmentOn September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Aug 5, 2025 | Undisclosed · Series A | 恩然创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 22, 2026 | — · Equity | 光华梧桐, 晓池资本, 梧桐聚云企管, 瑞尚医药 | No source link |
Evidence Yunhe Pharma Secures Equity InvestmentOn September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Aug 5, 2025 | — · Series A | 恩然创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI靶点发现、RNA序列优化与小核酸药物研发